» Articles » PMID: 36551411

Analysis of the Oral Microbiome in a Patient with Cardiofaciocutaneous Syndrome and Severe Periodontal Disease: Impact of Systemic Antibiotic Therapy

Abstract

An 8-year-old girl diagnosed with cardiofaciocutaneous syndrome presented to our department with gingival pain, inflammation, and bleeding. Her medical history included hypoplasia of the corpus callosum, intellectual disability, trichothiodystrophy, global developmental delay, myopia, laryngomalacia, hypothyroidism, and osteoporosis. A diagnosis was reached of "periodontitis as a direct manifestation of systemic diseases". During 9 years of follow-up, there were exacerbation episodes with spontaneous gum bleeding, ulcers in the interdental papilla, tooth mobility, and progressive tooth loss. Some of these exacerbation episodes resolved clinically with the administration of amoxicillin and metronidazole. We therefore proposed an oral microbiome study (subgingival and saliva samples) before and after antibiotic therapy. The most abundant genera at the subgingival level before administering antibiotics were , , , and . Of the 94 genera sequenced, 57 were less abundant in the post-treatment state than at baseline, particularly certain Gram-negative periodontal pathogens such as and . In contrast, other genera related to oral health, such as and , showed an increase after administering the antibiotic. In conclusion, periodontitis exacerbations as a direct manifestation of systemic disease can occasionally be controlled exclusively with systemic antibiotics, without the need for performing mechanical periodontal therapy. This clinical recovery is correlated to substantial changes in the oral microbiome, which lead to the recovery of eubiosis of the microbiota.

Citing Articles

Spotlight on therapeutic efficiency of green synthesis metals and their oxide nanoparticles in periodontitis.

Kiarashi M, Mahamed P, Ghotbi N, Tadayonfard A, Nasiri K, Kazemi P J Nanobiotechnology. 2024; 22(1):21.

PMID: 38183090 PMC: 10770920. DOI: 10.1186/s12951-023-02284-5.


Cross-cultural translation and modification of the revised oral assessment guide for oral health assessment by non-dentists.

Limpuangthip N, Komin O, Chaichaowarat J, Phumkor P BDJ Open. 2023; 9(1):42.

PMID: 37699888 PMC: 10497511. DOI: 10.1038/s41405-023-00168-2.


Recent advances in metal nanoparticles to treat periodontitis.

Nasiri K, Masoumi S, Amini S, Goudarzi M, Tafreshi S, Bagheri A J Nanobiotechnology. 2023; 21(1):283.

PMID: 37605182 PMC: 10440939. DOI: 10.1186/s12951-023-02042-7.

References
1.
Klindworth A, Pruesse E, Schweer T, Peplies J, Quast C, Horn M . Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies. Nucleic Acids Res. 2012; 41(1):e1. PMC: 3592464. DOI: 10.1093/nar/gks808. View

2.
Pierpont E, Kenney-Jung D, Shanley R, Zatkalik A, Whitmarsh A, Kroening S . Neurologic and neurodevelopmental complications in cardiofaciocutaneous syndrome are associated with genotype: A multinational cohort study. Genet Med. 2022; 24(7):1556-1566. DOI: 10.1016/j.gim.2022.04.004. View

3.
Giovannetti F, Aboh I, Chisci G, Gennaro P, Gabriele G, Cascino F . Langerhans cell histiocytosis: treatment strategies. J Craniofac Surg. 2014; 25(3):1134-6. DOI: 10.1097/SCS.0000000000000668. View

4.
Jurca M, Iuhas O, Puiu M, Chirita-Emandi A, Andreescu N, Petchesi C . Cardiofaciocutaneous syndrome - a longitudinal study of a case over 33 years: case report and review of the literature. Rom J Morphol Embryol. 2022; 62(2):563-568. PMC: 8848265. DOI: 10.47162/RJME.62.2.23. View

5.
Hajishengallis G, Lamont R . Beyond the red complex and into more complexity: the polymicrobial synergy and dysbiosis (PSD) model of periodontal disease etiology. Mol Oral Microbiol. 2012; 27(6):409-19. PMC: 3653317. DOI: 10.1111/j.2041-1014.2012.00663.x. View